- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07266558
Uno studio per valutare l'efficacia e la sicurezza di mRNA-1283 e mRNA-1273 in partecipanti di età compresa tra 50 e 64 anni senza condizioni ad alto rischio per la malattia da coronavirus 2019 (COVID-19) grave
Uno studio di Fase 4, randomizzato, in cieco per l'osservatore, controllato con placebo, per valutare l'efficacia e la sicurezza della formulazione contenente variante mRNA-1283 e mRNA-1273 in adulti di età compresa tra 50 e 64 anni senza condizioni sottostanti che li pongano ad alto rischio di esiti gravi da COVID-19
The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID-19.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 4
Contatti e Sedi
Luoghi di studio
-
-
Alabama
-
Birmingham, Alabama, Stati Uniti, 35216
- Accel Clinical Research
-
Cullman, Alabama, Stati Uniti, 35055
- Cullman Clinical Trials
-
Mobile, Alabama, Stati Uniti, 36608
- Velocity Clinical Research, Mobile
-
Mobile, Alabama, Stati Uniti, 36608
- AMR Clinical Mobile
-
-
Arizona
-
Glendale, Arizona, Stati Uniti, 85308
- Lenzmeier Family Medicine - Avacare
-
Mesa, Arizona, Stati Uniti, 85213
- Desert Clinical Research
-
Phoenix, Arizona, Stati Uniti, 85006
- Velocity Clinical Research - Phoenix
-
Phoenix, Arizona, Stati Uniti, 85044
- Foothills Research Center/Avacare
-
Scottsdale, Arizona, Stati Uniti, 85260
- Headlands Research Scottsdale
-
Tempe, Arizona, Stati Uniti, 85283
- Fiel Family and Sports Medicine / Avacare
-
-
California
-
Colton, California, Stati Uniti, 92324
- Avacare
-
Garden Grove, California, Stati Uniti, 92845
- CenExel CNR
-
Huntington Park, California, Stati Uniti, 90255
- Velocity Clinical Research, Huntington Park
-
La Mesa, California, Stati Uniti, 91942
- Velocity Clinical Research - San Diego - ERN - PPDS-Site Number:8400010
-
Los Angeles, California, Stati Uniti, 90017
- Velocity Clinical Research - Los Angeles
-
Riverside, California, Stati Uniti, 92503
- Artemis Institute for Clinical Research
-
Rolling Hills Estates, California, Stati Uniti, 90274
- Peninsula Research Associates
-
San Bernardino, California, Stati Uniti, 92408
- Velocity Clinical Research -- Banning
-
San Diego, California, Stati Uniti, 92103
- Artemis Institute for Clinical Research
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80238
- Tekton Research, LLC
-
Fort Collins, Colorado, Stati Uniti, 80525
- Tekton Research, LLC
-
Lakewood, Colorado, Stati Uniti, 80228
- Critical Care, Pulmonary and Sleep Associates, P.LLP/Avacare
-
Longmont, Colorado, Stati Uniti, 80501
- Tekton Research, LLC
-
-
Connecticut
-
Bridgeport, Connecticut, Stati Uniti, 06606
- New England Research Associates
-
Stamford, Connecticut, Stati Uniti, 06905
- Stamford Therapeutics Consortium
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stati Uniti, 20016
- Velocity Clinical Research-Washington, DC
-
-
Florida
-
DeLand, Florida, Stati Uniti, 32720
- Hillcrest Medical Research, LLC
-
DeLand, Florida, Stati Uniti, 32720
- University Clinical Research-Deland, LLC d/b/a Accel Research Sites - Deland Clinical Research Unit
-
Doral, Florida, Stati Uniti, 33172
- Suncoast Research Associates, LLC
-
Hallandale, Florida, Stati Uniti, 33009
- Velocity Clinical Research, Hallandale Beach
-
Hialeah, Florida, Stati Uniti, 33012
- Indago Research & Health Center, Inc
-
Hollywood, Florida, Stati Uniti, 33024
- CenExel Research Centers of America
-
Hollywood, Florida, Stati Uniti, 33024
- NextPhase Research Florida
-
Jupiter, Florida, Stati Uniti, 33458
- Health Awareness Inc.
-
Lakeland, Florida, Stati Uniti, 33803
- Sandhill Research, LLC d/b/a Accel Research Sites - Lakeland Clinical Research Unit
-
Largo, Florida, Stati Uniti, 33777
- Sandhill Research, LLC d/b/a Accel Research Sites- St. Pete-Largo Clinical Research Unit
-
Maitland, Florida, Stati Uniti, 32751
- Accel Research Sites
-
Miami Lakes, Florida, Stati Uniti, 33016
- Global Health Research Center, Inc.
-
New Port Richey, Florida, Stati Uniti, 34652
- Suncoast Clinical Research
-
Orlando, Florida, Stati Uniti, 32819
- Headlands Research Orlando
-
Palmetto Bay, Florida, Stati Uniti, 33157
- Innovation Medical Research Center
-
Tampa, Florida, Stati Uniti, 33613
- ForCare Clinical Research
-
Tampa, Florida, Stati Uniti, 33615
- Global Health Research Center, Inc.
-
-
Georgia
-
Albany, Georgia, Stati Uniti, 31707
- Javara Inc. and PRIVIA Medical Group of Georgia, LLC
-
Atlanta, Georgia, Stati Uniti, 30331
- Atlanta Center for Medical Research
-
Atlanta, Georgia, Stati Uniti, 30329
- DelRicht Research
-
Decatur, Georgia, Stati Uniti, 30030
- CenExel iResearch, LLC
-
Decatur, Georgia, Stati Uniti, 30030
- Accel Research Sites - Neurostudies
-
Fayetteville, Georgia, Stati Uniti, 30214
- Javara Inc. and Privia Medical Group of Georgia, LLC
-
Savannah, Georgia, Stati Uniti, 31406
- Velocity Clinical Research Savannah
-
Stockbridge, Georgia, Stati Uniti, 30281
- Clinical Research Atlanta
-
-
Idaho
-
Meridian, Idaho, Stati Uniti, 83642
- Velocity Clinical Research - Boise - ERN - PPDS
-
-
Illinois
-
Melrose Park, Illinois, Stati Uniti, 60160
- DM Clinical Research - Melrose Park
-
-
Indiana
-
Valparaiso, Indiana, Stati Uniti, 46383
- Velocity Clinical Research Valparaiso
-
-
Iowa
-
Sioux City, Iowa, Stati Uniti, 51106
- Velocity Clinical Research - Sioux City
-
-
Kansas
-
Lenexa, Kansas, Stati Uniti, 66212
- Johnson County Clin-Trials
-
Wichita, Kansas, Stati Uniti, 67218
- Tekton Research, LLC
-
-
Kentucky
-
Louisville, Kentucky, Stati Uniti, 40205
- DelRicht Research
-
Versailles, Kentucky, Stati Uniti, 40383
- Versailles Family Medicine - CCT Research
-
-
Louisiana
-
Baton Rouge, Louisiana, Stati Uniti, 70809
- Velocity Clinical Research-Baton Rouge
-
Covington, Louisiana, Stati Uniti, 70433
- Velocity Clinical Research - Covington
-
Kenner, Louisiana, Stati Uniti, 70065
- Avacare
-
Lafayette, Louisiana, Stati Uniti, 70508
- Velocity Clinical Research, Lafayette
-
Mandeville, Louisiana, Stati Uniti, 70471
- DelRicht Research
-
New Orleans, Louisiana, Stati Uniti, 70115
- DelRicht Research
-
New Orleans, Louisiana, Stati Uniti, 70119
- Velocity Clinical Research, New Orleans
-
Prairieville, Louisiana, Stati Uniti, 70769
- DelRicht Research
-
-
Maryland
-
Annapolis, Maryland, Stati Uniti, 21401
- Annapolis Internal Medicine
-
Columbia, Maryland, Stati Uniti, 21045
- Centennial Medical Group
-
Rockville, Maryland, Stati Uniti, 20854
- Velocity Clinical Research, Rockville
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02115
- Brigham and Women's Hospital
-
Brookline, Massachusetts, Stati Uniti, 02446
- DM Clinical Research - Brookline
-
Methuen, Massachusetts, Stati Uniti, 01844
- ActivMed Practices & Research, LLC
-
-
Michigan
-
Southfield, Michigan, Stati Uniti, 48076
- DM Clinical Research - Southfield
-
Southfield, Michigan, Stati Uniti, 48034
- Headlands Research Detroit
-
-
Minnesota
-
Mankato, Minnesota, Stati Uniti, 56001
- Javara Inc. and Mankato Clinic, Ltd.
-
-
Mississippi
-
Gulfport, Mississippi, Stati Uniti, 39503
- Velocity Clinical Research Gulfport
-
-
Missouri
-
Chesterfield, Missouri, Stati Uniti, 63005
- Clinical Research Professionals
-
Kansas City, Missouri, Stati Uniti, 64151
- Clay-Platte Family Medicine Clinic
-
Kansas City, Missouri, Stati Uniti, 64116
- AMR Clinical
-
Springfield, Missouri, Stati Uniti, 65807
- DelRicht Research
-
St Louis, Missouri, Stati Uniti, 63141
- Sundance Clinical Research, LLC
-
Town and Country, Missouri, Stati Uniti, 63017
- DelRicht Research
-
-
Nebraska
-
Fremont, Nebraska, Stati Uniti, 68025
- Avacare Research/Methodist Physicians Clinic
-
Grand Island, Nebraska, Stati Uniti, 68803
- Velocity Clinical Research, Grand Island
-
Lincoln, Nebraska, Stati Uniti, 68510
- Velocity Clinical Research
-
Norfolk, Nebraska, Stati Uniti, 68701
- Velocity Clinical Research Norfolk
-
Omaha, Nebraska, Stati Uniti, 68134
- Velocity Clinical Research Omaha
-
Omaha, Nebraska, Stati Uniti, 68144
- Avacare/Midwest Regional Health Services
-
Papillion, Nebraska, Stati Uniti, 68046
- Papillion Research/Avacare
-
-
Nevada
-
Las Vegas, Nevada, Stati Uniti, 89119
- Santa Rosa Medical Centers of Nevada
-
-
New Jersey
-
Jersey City, New Jersey, Stati Uniti, 07306
- DM Clinical Research - Jersey City
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87107
- Velocity Clinical Research - Albuquerque
-
Albuquerque, New Mexico, Stati Uniti, 87106
- DM Clinical Research - Albuquerque
-
-
New York
-
Rochester, New York, Stati Uniti, 14609
- Rochester Clinical Research
-
-
North Carolina
-
Durham, North Carolina, Stati Uniti, 27701
- Velocity Clinical Research, Durham
-
Raleigh, North Carolina, Stati Uniti, 27607
- Eximia Research - NC, LLC
-
Wilmington, North Carolina, Stati Uniti, 28403
- TMA Headlands LLC d/b/a Trial Management Associates
-
Winston-Salem, North Carolina, Stati Uniti, 27157
- Wake Forest University Health Sciences
-
-
Ohio
-
Beachwood, Ohio, Stati Uniti, 44122
- Velocity Clinical Research - Cleveland
-
Cincinnati, Ohio, Stati Uniti, 45212
- CTI Clinical Research Center
-
Cincinnati, Ohio, Stati Uniti, 45246
- Velocity Clinical Research Springdale
-
Cincinnati, Ohio, Stati Uniti, 45242
- Velocity Clinical Research-Mt. Auburn
-
-
Oklahoma
-
Edmond, Oklahoma, Stati Uniti, 73013
- Tekton Research, LLC
-
Moore, Oklahoma, Stati Uniti, 73160
- Tekton Research, LLC
-
Tulsa, Oklahoma, Stati Uniti, 74133
- DelRicht Research
-
Yukon, Oklahoma, Stati Uniti, 73099
- Tekton Research, LLC
-
-
Oregon
-
Medford, Oregon, Stati Uniti, 97504
- Velocity Clinical Research - Medford
-
Portland, Oregon, Stati Uniti, 97210
- Summit Headlands LLC
-
-
Pennsylvania
-
Horsham, Pennsylvania, Stati Uniti, 19044
- Hatboro Medical Associates/Avacare
-
Philadelphia, Pennsylvania, Stati Uniti, 19107
- DM Clinical Research - Philadelphia
-
-
Rhode Island
-
East Greenwich, Rhode Island, Stati Uniti, 02818
- Velocity Clinical Research - East Greenwich
-
-
South Carolina
-
Anderson, South Carolina, Stati Uniti, 29621
- Velocity Clinical Research, Anderson
-
Charleston, South Carolina, Stati Uniti, 29407
- DelRicht Research
-
Columbia, South Carolina, Stati Uniti, 29204
- Velocity Clinical Research - Columbia
-
North Charleston, South Carolina, Stati Uniti, 29405
- Coastal Carolina Research Center, LLC
-
Spartanburg, South Carolina, Stati Uniti, 29303
- Velocity Clinical Research Spartanburg
-
Union, South Carolina, Stati Uniti, 29379
- Velocity Clinical Research Union
-
-
Tennessee
-
Hendersonville, Tennessee, Stati Uniti, 37075
- DelRicht Research
-
-
Texas
-
Abilene, Texas, Stati Uniti, 79606
- Velocity Clinical Research, Abilene
-
Austin, Texas, Stati Uniti, 78745
- Tekton Research, LLC
-
Austin, Texas, Stati Uniti, 78759
- Velocity Clinical Research - Austin
-
Beaumont, Texas, Stati Uniti, 77706
- Tekton Research, LLC
-
Conroe, Texas, Stati Uniti, 77384
- Javara Inc. and Privia Medical Group Gulf Coast, PLLC
-
Dallas, Texas, Stati Uniti, 75230
- Velocity Clinical Research - Dallas
-
Fort Worth, Texas, Stati Uniti, 76135
- Avacare
-
Houston, Texas, Stati Uniti, 77065
- DM Clinical Research - Houston
-
Houston, Texas, Stati Uniti, 77081
- DM Clinical Research - Houston
-
Prosper, Texas, Stati Uniti, 75078
- DelRicht Research
-
Round Rock, Texas, Stati Uniti, 78681
- Be Well Clinical Studies
-
San Antonio, Texas, Stati Uniti, 78207
- DM Clinical Research - San Antonio
-
San Antonio, Texas, Stati Uniti, 78229
- Tekton Research, LLC
-
San Marcos, Texas, Stati Uniti, 78666
- Javara Inc. and Privia Medical Group Gulf Coast, PLLC
-
Stephenville, Texas, Stati Uniti, 76401
- Javara Inc. and Privia Medical Group - North Texas
-
Sugar Land, Texas, Stati Uniti, 77478
- DM Clinical Research - Sugar Land
-
Sugar Land, Texas, Stati Uniti, 77478
- Javara Inc. and Privia Medical Group Gulf Coast, PLLC
-
Sugar Land, Texas, Stati Uniti, 77479
- Olympus Clinical Research
-
Tomball, Texas, Stati Uniti, 77375
- DM Clinical Research - Tomball
-
-
Utah
-
Bountiful, Utah, Stati Uniti, 84010
- Cope Family Medicine / Avacare
-
Pleasant View, Utah, Stati Uniti, 84404
- Mountain View/Avacare
-
Salt Lake City, Utah, Stati Uniti, 84107
- JBR Clinical Research
-
Salt Lake City, Utah, Stati Uniti, 84117
- Olympus Family Medicine/Avacare
-
South Jordan, Utah, Stati Uniti, 84095
- J. Lewis Research, Inc/Jordan River Family Medicine
-
South Ogden, Utah, Stati Uniti, 84405
- South Ogden Family Medicine/ Avacare
-
West Jordan, Utah, Stati Uniti, 84088
- Velocity Clinical Research - Salt Lake City (West Jordan)
-
-
Virginia
-
Charlottesville, Virginia, Stati Uniti, 22911
- Charlottesville Medical Research, LLC
-
Hampton, Virginia, Stati Uniti, 23666
- Velocity Clinical Research-Hampton
-
Richmond, Virginia, Stati Uniti, 23226
- Clinical Research Partners, LLC
-
Suffolk, Virginia, Stati Uniti, 23435
- Velocity Clinical Research - Suffolk
-
-
Washington
-
Spokane, Washington, Stati Uniti, 99218
- Velocity Clinical Research, Spokane
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Key Inclusion Criteria:
- Healthy and without underlying medical conditions that may put them at higher risk of experiencing severe outcomes of COVID-19, as determined by medical evaluation including medical history, physical examination, laboratory tests, and cardiac monitoring.
Key Exclusion Criteria:
-
History of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within 3 months prior to enrollment.
-
Acutely ill or febrile within 72 hours prior to or at the Screening Visit or Day 1.
-
Receipt of any of the following:
- COVID-19 vaccine within 3 months prior to enrollment,
- Any licensed non COVID-19 vaccine within 28 days before or planned receipt within 28 days after the study intervention, except an influenza vaccine, which may be given 14 days before or after receipt of the study intervention,
- Corticosteroids at ≥10 milligrams (mg)/day of prednisone or equivalent for >14 days in total within 90 days prior to Day 1 or is anticipating the need for corticosteroids at any time during the study or,
- Systemic immunosuppressive treatment within 180 days prior to the Screening or is anticipating the need for systemic immunosuppressive treatment at any time during participation in the study.
-
Has donated ≥450 mL of blood products within 28 days prior to the Screening Visit or plans to donate blood products within 28 days post study injection.
-
Has participated in an investigational clinical study within 28 days prior to the Screening Visit based on the medical history interview or plans to do so while participating in this study.
Note: Additional inclusion/exclusion criteria may apply, per protocol.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: mRNA-1273 (Variant Formulation)
Participants will receive a single intramuscular (IM) injection of mRNA-1273 on Day 1. |
Sterile liquid for injection |
|
Sperimentale: mRNA-1283 (Variant Formulation)
Participants will receive a single IM injection of mRNA-1283 on Day 1. |
Sterile liquid for injection |
|
Comparatore placebo: Placebo
Participants will receive a single IM injection of placebo on Day 1. |
0.9% sodium chloride (normal saline) injection |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Numero di partecipanti con eventi avversi (EA) non sollecitati
Lasso di tempo: Dal Giorno 1 al Giorno 28
|
Dal Giorno 1 al Giorno 28
|
|
|
Numero di partecipanti con Eventi Avversi Gravi (EAG), Eventi Avversi con Assistenza Medica (EAAM), Eventi Avversi di Interesse Speciale (EAIS) ed Eventi Avversi che hanno Portato all'Interruzione
Lasso di tempo: Dal Giorno 1 al Giorno 181
|
Dal Giorno 1 al Giorno 181
|
|
|
VE of mRNA-1273 (Variant Formulation) to Prevent the First Event of COVID-19 after Study Injection
Lasso di tempo: Day 1 through Day 181
|
The VE is defined as the percent reduction in the hazard of the first event of COVID-19 after study injection (each vaccine arm versus placebo) and will be estimated using 1-hazard ratio (HR). |
Day 1 through Day 181
|
|
Vaccine Efficacy (VE) of mRNA-1283 (Variant Formulation) to Prevent the First Event of COVID-19 after Study Injection
Lasso di tempo: Day 1 through Day 181
|
The VE is defined as the percent reduction in the hazard of the first event of COVID-19 after study injection (each vaccine arm versus placebo) and will be estimated using 1-hazard ratio (HR). |
Day 1 through Day 181
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Numero di partecipanti con un primo evento di COVID-19 grave dopo l'iniezione dello studio
Lasso di tempo: Giorno 1 fino al Giorno 181
|
Giorno 1 fino al Giorno 181
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Infezioni delle vie respiratorie
- Infezioni
- Infezioni da virus a RNA
- Malattie virali
- Malattie delle vie respiratorie
- Malattie polmonari
- Polmonite, virale
- Polmonite
- Infezioni da Coronaviridae
- Infezioni da Nidovirus
- COVID-19
- Infezioni da coronavirus
- Aminoacidi, peptidi e proteine
- Proteine
- Fattori biologici
- Prodotti biologici
- Miscele complesse
- Vaccini
- Vaccini virali
- vaccini mRNA
- Vaccini a base di acido nucleico
- Vaccini, sintetici
- Proteine ricombinanti
- Vaccini contro il covid-19
- Antigeni
- 2019-ncov vaccino mRNA-1273
Altri numeri di identificazione dello studio
- mRNA-1273_1283-P401
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .